DYN Dyne Therapeutics, Inc.

HealthcareBiotechnology
$17.54
▼ 6.90%
41
QScore Signal
Hold
Confidence: MEDIUM
Long-Term
33
Short-Term
49

Value

30
P/E-5.05
8
P/B2.32
47
P/S0.00
70
EV/EBITDA-4.62
5

Growth

37
Revenue Growth0.0%
28
EPS Growth-3.0%
43
FCF Growth-37.4%
40

Momentum

71
12-Month Return75.0%
100
3-Month Return6.0%
70
1-Month Return-4.6%
45
RSI (14)31.34
50
50/200 MABullish
75

Profitability

18
ROE-61.5%
39
ROA-37.6%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-14.6%
0

Risk

41
Beta1.08
90
60-Day Volatility71.6%
0

Generated 5/7/2026, 10:49:13 PM · How is this calculated?

QScore Analysis